Form D · Hedge Fund

ArrowMark Life Science Fund II, LP

Denver, CO · CIK 0001895193

Offering snapshot reported Nov 30, 2021 · SEC filing

Reported sold: $71.9M
Investors reported: 104
Minimum accepted: $1M
First sale: Jun 1, 2021

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 30, 2021	Initial	$71,912,472	No comparison	104	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C.7, 3C
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-422861

Source: Form D, filed Nov 30, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ARROWMARK LIFE SCIENCE FUND, LP

Investment adviser: ARROWMARK COLORADO HOLDINGS, LLC

Gross asset value: $465K
Beneficial owners: 49
ADV minimum commitment: $1M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ALPS FUND SERVICES DENVER, Colorado, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Fund administrator SS&C TECHNOLOGIES INC. WINDSOR, Connecticut, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG DENVER, Colorado, United States

Custodian GOLDMAN SACHS & CO. LLC NEW YORK CITY, New York, United States Related to adviser: No

Prime broker GOLDMAN SACHS & CO. LLC NEW YORK CITY, New York, United States

Provider details

Annual audit: Yes
Prime brokers: Yes
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

KPMG
PCAOB 185

GOLDMAN SACHS & CO. LLC
SEC 8-129

GOLDMAN SACHS & CO. LLC
CRD 361 · SEC 8-129

Filing source

Form ADV 2056827 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-5593618566

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
N/A Amp Life Science Gp Ii, Llc	Executive, Promoter
N/A Arrow Mark Colorado Holdings, Llc	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

100 Fillmore Street, Suite 325
Denver, CO, 80206